codiagnostics.com - יחס שווי חברה להכנסות CODX

Co-Diagnostics, Inc. generates revenue from the supply of PCR systems and DNA analyzers to global clinics. The enterprise value-to-revenue ratio reflects market sentiment, where 3969.23 indicates the current value of this metric. The molecular center in Utah is scaling test production through external partners. A high degree of sequencing automation and bioinformatics ensure autonomous data processing.
CODX (Co-Diagnostics, Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The scale of Co-Diagnostics, Inc. (CODX) business and its patent-protected PCR technologies determine the current EV/Sales valuation at 3969.23. This ratio compares the total enterprise value to annual revenue regardless of debt load, measuring market equilibrium and management's ability to maintain capitalization amidst high regulatory barriers to entry in the molecular diagnostics sector.